288 filings
Page 2 of 15
8-K
srnqug4 6z
23 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
chs2o
4 May 23
Intra-cellular Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:37am
ARS
ipxj0 ylsfaczd
28 Apr 23
Annual report to shareholders
5:09pm
DEFA14A
9gqr6
28 Apr 23
Additional proxy soliciting materials
4:42pm
8-K
x2js6
28 Mar 23
Other Events
7:12am
8-K
mscw24xuvky2
1 Mar 23
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2022 Financial Results and Provides Corporate Update
7:41am
8-K
kpugjprgcoxn k71rltu
9 Jan 23
Entry into a Material Definitive Agreement
5:13pm
8-K
c8qli6nvmdroq6z
22 Dec 22
Entry into a Material Definitive Agreement
4:09pm
8-K
qysuy7kaz r5
3 Nov 22
Intra-cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:35am
8-K
reyyk h947zt61
9 Aug 22
Intra-cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:38am
8-K
e9zttypsyb mx5u
13 Jun 22
Submission of Matters to a Vote of Security Holders
5:01pm
8-K
iehkb5id0jo
10 May 22
Intra-cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:37am
8-K
t0tfg f7t5e4zgnyvnzv
25 Apr 22
Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA® (lumateperone) for Specific Patient Populations
7:12am
DEFA14A
h6f9f
21 Apr 22
Additional proxy soliciting materials
5:04pm